Immunology and Cell Biology of Parasitic DiseasesView this Special Issue
Research Article | Open Access
Paola Zaccone, Oliver T. Burton, Sarah Gibbs, Nigel Miller, Frances M. Jones, David W. Dunne, Anne Cooke, "Immune Modulation by Schistosoma mansoni Antigens in NOD Mice: Effects on Both Innate and Adaptive Immune Systems", BioMed Research International, vol. 2010, Article ID 795210, 11 pages, 2010. https://doi.org/10.1155/2010/795210
Immune Modulation by Schistosoma mansoni Antigens in NOD Mice: Effects on Both Innate and Adaptive Immune Systems
We have shown that Schistosoma mansoni egg soluble antigen (SEA) prevents diabetes in the nonobese diabetic (NOD) mouse inducing functional changes in antigen presenting cells (APCs) and expanding T helper (Th) 2 and regulatory T cell (Treg) responses. A Th2 response to S. mansoni infection or its antigens is key to both the establishment of tolerance and successfully reproduction in the host. More recently we demonstrated that SEA treatment upregulates bioactive TGF on T cells with consequent expansion of Tregs, and these cells might be important in SEA-mediated diabetes prevention together with Th2 cells. In this study we profile further the phenotypic changes that SEA induces on APCs, with particular attention to cytokine expression and markers of macrophage alternative activation. Our studies suggest that TGF from T cells is important not just for Treg expansion but also for the successful Th2 response to SEA, and therefore, for diabetes prevention in the NOD mouse.
Helminths employ a range of immunomodulatory strategies to modulate the host immune response and utilize it to extend their longevity in the host and facilitate transmission. Characteristic of infection with helminths such as Schistosoma mansoni is the induction of a Th2 response. Two products released from eggs have recently been shown to play important roles in the immune deviation induced by S. mansoni infection [1, 2]. The NOD mouse provides a good animal model of the human autoimmune disease, Type 1 diabetes . We have previously shown that S. mansoni infection or exposure either to the helminth eggs or soluble extracts of worms (SWA) or eggs (SEA) can prevent diabetes onset in this mouse [4–6].
As Type 1 diabetes is a Th1-mediated autoimmune disease , any skewing of the response towards Th2 would result in diabetes prevention. Other responses that have the potential to impact on diabetes would be the induction of immunoregulatory cytokines such as IL-10 and TGF and regulatory T cells (Tregs) [8, 9]. We and others have shown that both SEA and SWA have profound effects on cells of the innate immune system including dendritic cells (DCs) and NKT cells [5, 10, 11]. In the case of bone marrow derived DCs, it has been shown that exposure to S. mansoni antigens results in DC retention of a more immature phenotype while inducing them to mediate a Th2 response in vivo [5, 10]. Immature DCs have been associated with ability to induce a Th2 response as well as immune tolerance through induction of Tregs . Although there was little evidence of phenotypic change in SEA exposed bone marrow derived murine DCs, recent studies showed increased expression of mannose receptor (MR), DEC-205, and DC-SIGN as well as induction of IL-10 . SEA has, furthermore, been shown to induce Foxp3 expressing Tregs in a TGF dependent manner . Most studies in mice have been carried out using bone marrow derived APCs and it could be argued that it would be more relevant to examine the effect of S. mansoni antigens on isolated splenic DCs as well as in vivo on macrophage (M) populations. In this manuscript we have addressed in detail the effect of SEA on functional and phenotypic changes in DCs and Ms and the impact that this might have on the development of different T cell subpopulations including Tregs.
2. Materials and Methods
Female NOD/Tac mice were housed and barrier bred in the Pathology Department, University of Cambridge animal facilities (Cambridge, UK) and used between 4–12 weeks of age. All work was conducted under UK Home Office project license regulations after approval by the Ethical Review Committee of the University of Cambridge.
2.2. Preparation of SEA and SWA
Preparation of SEA and SWA was described previously . Briefly, for SEA, eggs were harvested from the livers of outbred infected mice, which were treated to prevent granuloma formation. Livers were homogenized through sieves and the eggs were collected, washed, and sonicated in PBS on ice, prior to centrifugation to separate the saline soluble fraction. SWA was prepared from adult worms recovered from the portal venous vasculature. Both antigens were sterile filtered and endotoxin removed to below 1 EU/mg using Polymixin B agarose beads (Sigma).
2.3. Cell Culture and Reagents
Cells were cultured in Iscove’s modified Dulbecco’s medium supplemented with 2 mM L-glutamine, 100 U/ml penicillin-streptomycin, 50 2-mercaptoethanol (All Sigma), and 5%–10% fetal calf serum (FCS) (Gibco). Anti-CD3 (CD3) (2C11) and CD28 (37.51) were obtained from BD Pharmingen. LPS from Salmonella enterica (Sigma) and the TLR1/2 agonist Pam3CysK4 (Invivogen) were used to stimulate DCs. Anti-TGF (1D11.16) was precipitated from hybridoma supernatants and dialyzed against PBS before use.
2.4. TGF Bioassay
The MLE/PAI cell line is derived from mink lung epithelial cells and contains firefly luciferase under PAI-1 promoter control. MLE cells were cultured with 50 L of tissue culture supernatants or a double-dilution standard curve derived from recombinant human TGF1 (R&D Systems) for 18 hours. Cells were then lysed and luciferase activity was measured using Promega’s Luciferase Reporter System and a BetaLux scintillation counter (Wallac).
2.5. Flow Cytometry
Cells were stained with appropriate combinations of the following antibodies:
CD4 (RM4-5)-PCP-Cy5.5, CD25 (PC61)-PE, CD44 (IM7)-FITC, CD11b (M1/70)-PCP-Cy5.5, CD11c (HL3)-FITC or APC, galectin-3 (M3/38)-Alexa647, Foxp3 (FJK-16s)-Alexa647, CD205/DEC-205 (NLDC-145)-FITC, CD206/MR (MR5D3)-FITC, PD-L1 (M1H5)-PE, CD1d (1B1)-FITC, SIGN-R1 (22D1)-Alexa647, IL-4 (11B11)-PE, IL-17 (TC11-18H10)-PE, IL-10 (JES5-16A3)-APC, IL-13 (eBio13A)-Alexa647, and IFN (XMG1.2)-PE-Cy7. Appropriate isotype control antibodies were from the same manufacturer as for the specific antibody. Biotinylated polyclonal rat anti-mouse galectin-1 (R&D Systems) was used in conjunction with streptavidin-PE (BD Biosciences). Intracellular Foxp3 staining was according to the manufacturer’s instructions (anti-mouse/rat Foxp3 staining set; eBioscience). For intracellular cytokine staining, cells were stimulated for 5 hours with 0.5 g/mL PdBU, and ionomycin and cytokine secretion was blocked using 1 g/mL brefeldin A (all Sigma). Cells were fixed promptly in 1% paraformaldehyde PBS and permeabilized with 0.5% saponin (Sigma) in staining buffer. For live cell discrimination, 7-aminoactinomycin D (BD Biosciences) was used. For all staining, Fc receptor ligation was blocked using anti-FcR 2.4G2 supernatant grown in house. Cells were acquired using a BD FACScalibur, a BD FACScan (BD Biosciences), or a CyAn-ADP (Beckman Coulter) and analyzed using FlowJo (TreeStar) software.
2.6. Cell Purification
Naïve T cells (98% pure) were sorted from splenic cell suspensions on the basis of CD4+CDCD25− using a MoFlo (Beckman Coulter). Splenic dendritic cells (90% pure) were purified by immunomagnetic selection on an autoMACS Pro (Miltenyi Biotec). Briefly, spleens were digested using Liberase CI (Roche) and passed through a 70 m strainer to obtain a single-cell suspension. Nonspecific binding was blocked using 2.4G2 anti-FcR supernatant, and DCs were positively selected using pan-DC microbeads (Miltenyi Biotec). For T cell polarization, immature DCs were differentiated from bone marrow precursors using GM-CSF as previously described . Peritoneal exudates cells, PECs (50% CD11 Ms), were flushed from the peritoneal cavity by lavage with cold PBS. Pancreatic and hepatic leukocytes populations were isolated from collagenase digested samples by centrifugation through a 33% Percoll (GE Healthcare) gradient as previously described (EJI).
2.7. RNA Isolation and Real-Time RT-PCR
Total RNA was extracted using an RNeasy Mini kit, converted to cDNA using a Reverse Transcription kit, and quantified in real time using SYBR green fast PCR (all Qiagen). cDNA was analyzed in duplicate reactions with amplification of target gene and housekeeping gene (hypoxanthine phosphoribosyl transferase 1, Hprt1) transcripts performed on the same reaction plate on a 7500 fast real-time PCR system (Applied Biosystems). Proprietary QuantiTect Primer Assays for all genes were purchased from Qiagen. Data are presented after normalization to the threshold cycle (CT) for Hprt1, either as or as .
Statistical analyses were performed using GraphPad Prism 4 software. Tests performed and calculated two-tailed values are indicated in the individual figure legends. For nonparametric datasets, the Mann Whitney unpaired test was employed.
3.1. SEA Induces Functional and Phenotypic Changes on Dendritic Cells, Creating the Ideal Conditions for Th2 and Treg Cell Expansion
SEA triggers important changes in dendritic cell (DC) function, which are key in initiating modulation of the host immune system [14–19]. In the absence of additional TLR stimuli, we have shown that small consistent phenotypic changes occur when DCs are stimulated in vitro with SEA . This is particularly seen with C-type lectin receptors (CLRs). These receptors such as DEC-205, SIGN-R1, MR, and galectins 1 and 3, expressed on the surface of APCs, have been shown to recognize glycans present in schistosome antigens and are important for adaptive responses induced by the parasite [20–25]. Here we confirm that primary splenic DCs stimulated in vitro with SEA also upregulate the surface expression of galectins 1 and 3, and SIGN-R1, thus possibly increasing their ability to bind schistosome self-glycans (Figure 1(a)). Using bone marrow generated DCs, we have shown that the IL-10/IL-12 axis can be tilted by SEA [5, 6]. In Figures 1(b) and 1(c) we show that purified spleen CD11c+ DCs stimulated in vitro with SEA in the presence of TLR ligands upregulate the secretion of bioactive TGF whereas IL-12 (p40 and p35) mRNA expression is downmodulated.
Interestingly, SEA in association of Pam3CysK4 (a TLR1/2 ligand) induces the secretion of bioactive TGF, but this effect is not seen in combination with LPS (TLR4) or FSL-1 (TLR2/6, Figure 1(b)). No significant changes were found in IL-10 mRNA expression from purified splenic DCs (Figure 1(c)).
3.2. SEA Alternatively Activates Ms, which May Favor Treg and Th2 Cell Expansion In Vivo
We examined the effect of i.p. injected SEA on cellular phenotypes and function in the peritoneal cavity of NOD female mice. Examination of cytokine expression at the RNA level revealed that, while IL-4 mRNA was not detected in the control peritoneal cells (PECs), there was a substantial expression in PECs from SEA-treated mice, together with increased expression of IL-2, IL-6, IL-10, and TGF (Figure 2(a)). Interestingly, IL-12p35 expression was not affected by SEA while IL-12p40 was upregulated (Figure 2(a)). Expression of other subunits of the IL-12 family (EBI3, p28 for IL-27 and p19 for IL-23) was not affected by SEA treatment (data not shown). The significant upregulation of TGF suggests the presence of alternatively activated macrophages (aaMs) in PECs from SEA-treated mice and the increased expression of integrin 8 (Figure 2(a)) indicates an increased capacity to activate TGF at the point of the immunological synapse . Further support for the presence of aaMs is the upregulated expression of arginase-1 and 2 as well as Fizz-1 (Figure 2(b)). By comparison, treatment of NOD mice with LPS increased iNOS expression but, unlike with SEA, the full range of markers of alternative activation was not seen (Figure 2(c)).
Analysis of surface marker expression on PECs identified potentially relevant costimulatory molecules that might indicate the presence of aaMs as well as CLRs involved in the binding of SEA. After SEA injection there is an increased percentage of cells expressing MR on peritoneal Ms (pMs) with no significant change in mean fluorescent intensity (MFI) (Figure 3(a)). This increased surface expression was mirrored by an augmented receptor mRNA expression in whole PECs. The expression of SIGN-R1 and Dectin-1 was not altered by SEA when measured by FACS or by RT-PCR (data not shown).
Galectin-3 expression has been shown to be a feature of aaMs and its upregulation is IL-4 dependent . Following SEA injection we find an increased percentage of galectin-3-expressing pMs and upregulation of both galectin 1 and 3 mRNA (Figure 3(b)). SEA increased PD-L1 expression on pMs, with an accompanying increase in message for PD-L1 and 2 in whole PECs (Figure 3(c)). At this time point SEA also increased the expression of MHC class II (data not shown) and the nonclassical class I molecule CD1d (Figure 3(d)). The negative costimulatory molecule programmed death ligand 1 (PD-L1) has been shown to be upregulated on aaMs .
Altogether our findings indicate that SEA alternatively activates Ms in the peritoneal cavity and suggests that this anti-inflammatory signature might be tied to expansion of Tregs and Th2 cells.
3.3. SEA Induces IL-4, IL-10, and IFN-/IL-10 Double Producing T Cells In Vivo
Schistosome antigens are powerful inducers of Th2 responses, and this has been extensively explored using splenic and peripheral lymph node cells [29, 30]. In this study, we have extended our analysis to the pancreas in order to assess the potential impact of exposure to helminth antigens on diabetes and on the liver, the major site of immunopathology in schistosome infection. Kupffer cells, specialized liver Ms, have also been shown to initiate Th2 responses to egg antigens, and we have previously observed changes in classical NKT cell populations in the liver following schistosome antigen treatment of NOD mice . After a short course of treatment with SEA, the intracellular cytokine expression in CD4+ T cells is profoundly changed in the spleen, pancreas, and liver of prediabetic NOD mice (Figures 4(a), 4(b), and 4(c)). The systemic Th2/Treg response induced by SEA is accompanied by the signature of M alternative activation in the pancreatic infiltrate of prediabetic NOD mice and is presumably beneficial for diabetes prevention (Figures 4(b) and 4(d)).
Together with the expected Th2  and IL-10 Tr1 (CD4+ IL-10+) response, we have identified a population of CD4+ T cells expressing both IL-10 and IFN in response to SEA (Figures 4(b) and 4(c)). As IL-10-producing Th1 cells have been proposed as a self-regulating class of Th1 cells, the presence of this CD4+ T cell population in the pancreas might also mitigate Th1 driven diabetes pathology.
3.4. TGF Is Also Important for SEA Th2-Induced Response In Vivo and In Vitro
We have previously demonstrated that TGF is important for the generation and expansion of Foxp3+ Tregs in NOD mice . Our preliminary experiments suggest that the Th2 response induced by SEA can also be regulated by TGF. Figure 5(a) shows that the increased percentage of IL-4/IL-13 double-producing CD4+ T cells that we observe in SEA-treated NOD mice can be decreased by in vivo coadministration of SEA together with a TGF neutralizing antibody. This effect is particularly evident in the pancreas and not the spleen or PLN (Figure 5(a) and data not shown).
We have also confirmed our findings with an in vitro polarization assay. Using bone marrow generated DCs and naïve T cells from NOD mice, we have previously shown that SEA increases Foxp3+ Tregs in vitro and that TGF neutralization reverts this effect . Figure 5(b) shows that blocking TGF in vitro reduces the generation of IL-10 and IL-4 single- and double-producing CD4+ T cells. Also in vitro we observe that SEA can induce the generation of IL-10/IFN double-expressing CD4+ T cells and that TGF regulates this population. These preliminary data suggest that the role of TGF in adaptive responses to schistosome antigens is quite complex and is not restricted to the generation/expansion of Foxp3+ Tregs.
3.5. Egg But Not Worm S. mansoni Soluble Antigens Induce Foxp3+ Tregs In Vivo and In Vitro
We have recently suggested that Foxp3+ Tregs have an important role to play in SEA immunomodulation and prevention of autoimmunity in the NOD mouse . We found that in vitro only SEA, and not SWA, was able to induce Foxp3 in naïve T cells from NOD mice. To examine the effects of these helminth antigens on Tregs in vivo, we injected SEA and SWA into NOD mice.
Figure 6(a) shows that following a short in vivo treatment with S. mansoni antigens Foxp3+ Tregs increase only in SEA, but not SWA-treated mice. Further analysis of the liver of SEA-treated NOD mice revealed a highly significant increase in Foxp3+ Tregs, which is consistent with the fact that Tregs are found in the egg-induced granulomas in the liver and regulate their formation (Figure 6(b)) [31, 32].
These in vivo studies, therefore, support our in vitro studies and emphasize differences between the modes of activity of SEA and SWA.
There has been considerable interest in defining the ways in which S. mansoni infection perturbs the immune system and induces a Th2 response. As we have previously shown that S. mansoni antigens are able to inhibit the Th1-mediated autoimmune disease Type 1 diabetes, we were particularly interested in clarifying this in NOD mice.
We focused our attention on DCs and Ms as these cell types play a role in orchestrating the adaptive immune response. Much work has been carried out examining the effects of SEA on in vitro generated DCs, and while this has produced valuable insights, we felt that it is important to analyze the effects on populations of cells which would be exposed to S. mansoni antigens in vivo.
In our studies of splenic DCs we showed that following exposure to SEA in vitro these cells upregulated galectins 1 and 3, SIGN-R1, and DEC-205 following exposure to SEA in vitro. This is interesting because these C-type lectin receptors (CLRs) have been shown to recognize glycans present in schistosome antigens and are important for adaptive responses induced by the parasite. Galectins are of particular interest as they have the potential to alter sensitivity to cytokines and apoptosis [20, 33]. Exposure to SEA upregulates, therefore, the capacity of the DC to respond to further exposure to helminth glycans.
Some differences were observed in the response of DCs and Ms to SEA. This was seen in the effects of SEA on IL-12. In vitro, we found that splenic DCs downmodulated IL-12p35 and p40 in response to SEA whereas the in vivo response of pMs showed an upregulation of the IL-12p40 response with no effect on IL-12p35 (Figure 2(a)). This presents another interesting way in which the Th1 response could be modulated as it has been suggested that excess IL-12p40 in both a monomeric (p40) and dimeric (p80) forms might antagonize the IL-12 receptor , providing a feedback mechanism to downmodulate Th1 responses.
With regard to effects of SEA administration in vivo on APC phenotype and function, several were noted that again had the potential to modify a diabetogenic Th1 response. SEA increased PD-L1 expression on pMs, with an accompanying increase in message for PD-L1 and 2 in whole PECs (Figure 3(c)). The negative costimulatory molecule programmed death ligand 1 (PD-L1) has been shown to be upregulated on aaMs , as well as playing a role in diabetes regulation in NOD mice . Effects of i.p. injected SEA were noted in several sites, some of which were particularly relevant to diabetes regulation. After a short course treatment of NOD mice with SEA, the intracellular cytokine expression in CD4+ T cells was profoundly changed in the spleen, pancreas, and liver of prediabetic NOD mice (Figures 4(a), 4(b), and 4(c)). The systemic Th2/Treg response induced by SEA was accompanied by the signature of M alternative activation in the pancreatic infiltrate of prediabetic NOD mice and would be beneficial for diabetes prevention (Figures 4(b) and 4(d)). Together with the expected Th2  and IL-10 Tr1 (CD4+ IL-10+) response, we have identified a population of CD4+ T cells expressing both IL-10 and IFN in response to SEA (Figures 4(b) and 4(c)). IL-10/IFN double-producing CD4+ T cells were first identified in murine model of Leishmania infection and shown to mediate chronic pathology in the skin lesions with delayed/reduced clearance of infection [36, 37]. IL-10-producing Th1 cells have been proposed as a self-regulating class of Th1 cells, and therefore, this CD4+ T cell population in the pancreas might also mitigate Th1 driven diabetes pathology.
We have previously demonstrated that SEA has direct effects on DCs and T cells and suggest that the simultaneous interaction with both cell types is important for determining the host immune response. These in vitro studies had highlighted a role for TGF in the SEA-mediated induction of regulatory T cells; here we provide data suggesting that this immunomodulatory cytokine may also play a role in modulating the Th2 response in vivo as well as in vitro.
S. mansoni and its soluble antigens can prevent autoimmune diabetes in NOD mice. This paper summarizes and confirms our previous work demonstrating that SEA modulates the immune response through alteration of CLR expression, cytokine production, and Treg expansion in NOD mice. In particular we show how functional and phenotypic changes on DCs and Ms, the expansion of different T helper cell subsets (Th2), and Treg cell types (IL-10/IFN- double producers and Foxp3+ Tregs) might contribute to diabetes prevention in NOD mice (Figure 7).
|SEA:||S. mansoni soluble egg antigens|
|Treg:||Regulatory T cell|
|CLR:||C-type lectin receptor|
|RT-PCR:||Reverse transcriptase polymerase chain reaction|
|Hprt-RE:||Expression relative to hypoxanthine phosphoribosyl transferase*1000|
|PLN:||Pancreatic lymph node|
The authors would like to thank Dr. Jenny Phillips for facilitating this research. The authors would also like to acknowledge the BBSRC, The Wellcome Trust, and the MRC for their support of our projects. Oliver Burton is funded by a Herchel Smith Fellowship from Williams College (MA, USA). Paola Zaccone and Oliver T. Burton contributed equally to this work.
- B. Everts, G. Perona-Wright, H. H. Smits et al., “Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses,” The Journal of Experimental Medicine, vol. 206, no. 8, pp. 1673–1680, 2009.
- S. Steinfelder, J. F. Andersen, J. L. Cannons et al., “The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1),” The Journal of Experimental Medicine, vol. 206, no. 8, pp. 1681–1690, 2009.
- S. Makino, K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino, “Breeding of a non-obese, diabetic strain of mice,” Jikken Dobutsu, vol. 29, no. 1, pp. 1–13, 1980.
- A. Cooke, P. Tonks, F. M. Jones et al., “Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice,” Parasite Immunology, vol. 21, no. 4, pp. 169–176, 1999.
- P. Zaccone, Z. Fehérvári, F. M. Jones et al., “Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes,” European Journal of Immunology, vol. 33, no. 5, pp. 1439–1449, 2003.
- P. Zaccone, O. Burton, N. Miller, F. M. Jones, D. W. Dunne, and A. Cooke, “Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice,” European Journal of Immunology, vol. 39, no. 4, pp. 1098–1107, 2009.
- D. Bending, H. De La Pena, M. Veldhoen et al., “Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice,” The Journal of Clinical Investigation, vol. 119, no. 3, pp. 565–572, 2009.
- E. Sgouroudis and C. A. Piccirillo, “Control of type 1 diabetes by regulatory T cells: lessons from mouse models and implications for human disease,” Diabetes/Metabolism Research and Reviews, vol. 25, no. 3, pp. 208–218, 2009.
- J. M. Phillips, N. M. Parish, M. Drage, and A. Cooke, “Cutting edge: interactions through the IL-10 receptor regulate autoimmune diabetes,” The Journal of Immunology, vol. 167, no. 11, pp. 6087–6091, 2001.
- A. S. MacDonald, A. D. Straw, B. Bauman, and E. J. Pearce, “CD8- dendritic cell activation status plays an integral role in influencing Th2 response development,” The Journal of Immunology, vol. 167, no. 4, pp. 1982–1988, 2001.
- E. J. Pearce, C. M. Kane, and J. Sun, “Regulation of dendritic cell function by pathogen-derived molecules plays a key role in dictating the outcome of the adaptive immune response,” Chemical Immunology and Allergy, vol. 90, pp. 82–90, 2006.
- A. W. Thomson and P. D. Robbins, “Tolerogenic dendritic cells for autoimmune disease and transplantation,” Annals of the Rheumatic Diseases, vol. 67, supplement 3, pp. iii90–iii96, 2008.
- D. W. Dunne, A. E. Butterworth, A. J. Fulford et al., “Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection,” European Journal of Immunology, vol. 22, no. 6, pp. 1483–1494, 1992.
- C. M. Kane, L. Cervi, J. Sun et al., “Helminth antigens modulate TLR-initiated dendritic cell activation,” The Journal of Immunology, vol. 173, no. 12, pp. 7454–7461, 2004.
- C. M. Kane, E. Jung, and E. J. Pearce, “Schistosoma mansoni egg antigen-mediated modulation of Toll-like receptor (TLR)-induced activation occurs independently of TLR2, TLR4, and MyD88,” Infection and Immunity, vol. 76, no. 12, pp. 5754–5759, 2008.
- F. Trottein, N. Pavelka, C. Vizzardelli et al., “A type I IFN-dependent pathway induced by Schistosoma mansoni eggs in mouse myeloid dendritic cells generates an inflammatory signature,” The Journal of Immunology, vol. 172, no. 5, pp. 3011–3017, 2004.
- A. S. MacDonald, A. D. Straw, N. M. Dalto, and E. J. Pearce, “Cutting edge: Th2 response induction by dendritic cells: a role for CD401,” The Journal of Immunology, vol. 168, no. 2, pp. 537–540, 2002.
- D. Artis, C. M. Kane, J. Fiore et al., “Dendritic cell-intrinsic expression of NF- B1 is required to promote optimal Th2 cell differentiation,” The Journal of Immunology, vol. 174, no. 11, pp. 7154–7159, 2005.
- E. van Riet, B. Everts, K. Retra et al., “Combined TLR2 and TLR4 ligation in the context of bacterial or helminth extracts in human monocyte derived dendritic cells: molecular correlates for Th1/Th2 polarization,” BMC Immunology, vol. 10, article 9, 2009.
- T. K. van den Berg, H. Honing, N. Franke et al., “LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition,” The Journal of Immunology, vol. 173, pp. 1902–1907, 2004.
- E. van Liempt, A. Imberty, C. M. Bank et al., “Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens,” The Journal of Biological Chemistry, vol. 279, pp. 33161–33167, 2004.
- E. van Liempt, S. J. van Vliet, A. Engering et al., “Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation,” Molecular Immunology, vol. 44, no. 10, pp. 2605–2615, 2007.
- S. S. Saunders, C. M. Walsh, J. L. Barlow et al., “The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro but SIGNR1-deficient mice have normal responses during schistosome infection,” Infection and Immunity, vol. 77, no. 1, pp. 399–404, 2008.
- F. L. Oliveira, P. Frazão, R. Chammas et al., “Kinetics of mobilization and differentiation of lymphohematopoietic cells during experimental murine schistosomiasis in galectin-3-/- mice,” Journal of Leukocyte Biology, vol. 82, no. 2, pp. 300–310, 2007.
- L. Breuilh, F. Vanhoutte, J. Fontaine et al., “Galectin-3 modulates immune and inflammatory responses during helminthic infection: impact of galectin-3 deficiency on the functions of dendritic cells,” Infection and Immunity, vol. 75, no. 11, pp. 5148–5157, 2007.
- P. J. Wipff and B. Hinz, “Integrins and the activation of latent transforming growth factor 1—an intimate relationship,” European Journal of Cell Biology, vol. 87, no. 8-9, pp. 601–615, 2008.
- A. C. MacKinnon, S. L. Farnworth, P. S. Hodkinson et al., “Regulation of alternative macrophage activation by galectin-3,” The Journal of Immunology, vol. 180, no. 4, pp. 2650–2658, 2008.
- L. I. Terrazas, D. Montero, C. A. Terrazas, J. L. Reyes, and M. Rodríguez-Sosa, “Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis,” International Journal for Parasitology, vol. 35, no. 13, pp. 1349–1358, 2005.
- E. J. Pearce, C. M. Kane, J. Sun, J. J. Taylor, A. S. McKee, and L. Cervi, “Th2 response polarization during infection with die helminth parasite Schistosoma mansoni,” Immunological Reviews, vol. 201, pp. 117–126, 2004.
- A. S. McKee and E. J. Pearce, “ cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development,” The Journal of Immunology, vol. 173, no. 2, pp. 1224–1231, 2004.
- M. Baumgart, F. Tompkins, J. Leng, and M. Hesse, “Naturally occurring regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation,” The Journal of Immunology, vol. 176, no. 9, pp. 5374–5387, 2006.
- L. E. Layland, R. Rad, H. Wagner, and C. U. Prazeres da Costa, “Immunopathology in schistosomiasis is controlled by antigen-specific regulatory T cells primed in the presence of TLR2,” European Journal of Immunology, vol. 37, no. 8, pp. 2174–2184, 2007.
- E. A. Partridge, C. Le Roy, G. M. Di Guglielmo et al., “Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis,” Science, vol. 306, no. 5693, pp. 120–124, 2004.
- A. M. Cooper and S. A. Khader, “IL-12p40: an inherently agonistic cytokine,” Trends in Immunology, vol. 28, no. 1, pp. 33–38, 2007.
- M. J. I. Ansari, A. D. Salama, T. Chitnis et al., “The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice,” The Journal of Experimental Medicine, vol. 198, no. 1, pp. 63–69, 2003.
- Y. Belkaid, “Regulatory T cells and infection: a dangerous necessity,” Nature Reviews Immunology, vol. 7, no. 11, pp. 875–888, 2007.
- Y. Belkaid, K. F. Hoffmann, S. Mendez et al., “The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure,” The Journal of Experimental Medicine, vol. 194, no. 10, pp. 1497–1506, 2001.
Copyright © 2010 Paola Zaccone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.